Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02961309 · ClinicalTrials.gov registry record · Phase 1
A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking
A Phase 1 study, sponsored by Battelle Memorial Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT02961309 is a Phase 1 study that has completed, run by Battelle Memorial Institute. The registered enrollment target is 9 participants.
The verdict
NCT02961309, a Phase 1 study, has completed, sponsored by Battelle Memorial Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The objective of the proposed research is to investigate how smoking increasing potency of THC (i.e., the psychoactive ingredient in marijuana) changes tobacco cigarette smoking behavior, urges, subjective effects, and abuse liability. This study will be a within-subjects, placebo-controlled study in our clinical laboratory of the effect of active vs. placebo marijuana on cigarette puff topography, exhaled carbon monoxide, urge, subjective effects, and abuse liability among 7 adults who smoke both marijuana and tobacco cigarettes.
Interventions
- DRUG THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02961309
The ClinicalTrials.gov registry entry for NCT02961309 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Battelle Memorial Institute, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which THC is the first listed.
NCT02961309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02961309 about?
NCT02961309 is a clinical study titled "A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking". The objective of the proposed research is to investigate how smoking increasing potency of THC (i.e., the psychoactive ingredient in marijuana) changes tobacco cigarette smoking behavior, urges, subjective effects, and abuse liability. This study will be a within-subjects, placebo-controlled study i...
What is the current status of trial NCT02961309?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2018-05-07. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT02961309?
The interventions under investigation include: THC (DRUG).
Who is sponsoring clinical trial NCT02961309?
This trial is sponsored by Battelle Memorial Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.